Fundraising Fox

Exalys Therapeutics

San Diego, US · Founded 2018 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

EW
Eckard Weber, M.D.Named on SEC filing
MS
Michael SandersNamed on SEC filing
NV
Nicole VitulloNamed on SEC filing
DP
Dennis PodlesakNamed on SEC filing
RO
Rick OrrNamed on SEC filing
LR
Lynne RollinsNamed on SEC filing

Board

TTTakeshi Takahashi
Takeshi TakahashiinBoard directorManaging Director at Catalys Pacific
BT
Brian Taylor SlingsbyBoard directorFounder & Managing Director, MD, PhD, MPH at Catalys Pacific

Investors · 1

Catalys PacificreportedTokyovia Brian Taylor Slingsby · board

Reported raises · per SEC filings

Form D private placements

$4M disclosed across 1 round · 2020

▶$4MraisedApr 2020 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Takeshi TakahashiDirector
  • Eckard Weber, M.D.Director
  • Michael SandersExecutive Officer
  • Nicole VitulloDirector
  • Dennis PodlesakExecutive Officer, Director
  • Brian Taylor SlingsbyDirector
  • Rick OrrDirector
  • Lynne RollinsExecutive Officer
Offering amount
$25M
Amount sold
$4M
First sale
Apr 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Exalys Therapeutics went on to found or lead other companies.

Takeshi TakahashiDirectorFounded Aculys Pharma +2Brian Taylor SlingsbyDirectorFounded Mineralys Therapeutics

Frequently asked questions

Who are Exalys Therapeutics's investors?
Exalys Therapeutics's investors include Catalys Pacific.
How much funding has Exalys Therapeutics raised?
Exalys Therapeutics has disclosed $4M raised across 1 round.
Where is Exalys Therapeutics headquartered?
Exalys Therapeutics is headquartered in San Diego, US.